Greenwich LifeSciences, Inc. GLSI

Full chart Compare
Set alert

Price alert · GLSI

All alert types
14.65 USD -1.70 (-10.40%)

At closeNov 5, 2026, 4:20 PM EST

14.65 0.00 0.00%

After hours · Nov 5, 4:20 PM ET

14.11 Day range 16.22
7.78 52-week range 34.10
YTD
-30.27%
1 year
+75.03%

Discussion (77)

Sign in to join the discussion

Beautiful Vacations By Scotty GLSI 4 years ago #2

$GLSI

STAFFORD, Texas--(BUSINESS WIRE)-- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of GLSI-100, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, today announced that the Company will participate in the following interviews and conferences.

Today at 5:00 pm, the Company’s management team will be presenting two posters at the 2021 San Antonio Breast Cancer Symposium (SABCS) in person. The Company anticipates making the SABCS Phase IIb poster available on its website by the morning of December 9, exactly one year after the 2020 SABCS poster was published showing that no metastatic breast cancer recurrences were observed over 5 years of follow-up in HER2 positive patients who were fully treated. On December 9 at 2:20 pm ET, Snehal Patel, CEO of Greenwich LifeSciences, will appear as a featured guest in a live interview on TD Ameritrade Network's The Watch List with host Nicole Petallides to discuss the poster.

rhodeisland GLSI 5 years ago #8

There full report was posted on yahoo today
Only few days late

Wonder if this is going to pop today